Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | STAT6 | P42226 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.31 |
| ▸ | WHR1 | P49842 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3549460 | 0.91 | CTSB (0.35) | CTSBADRB3ADRA2BADRA2CKDM4E | |
| SCHEMBL2835262 | 0.89 | CTSB (0.43) | CTSBADRB3ADRA2BADRA2CKDM4E | |
| SCHEMBL8248165 | 0.89 | CTSB (0.43) | CTSBADRB3ADRA2BADRA2CKDM4E | |
| SCHEMBL2835252 | 0.89 | CTSB (0.43) | CTSBADRB3ADRA2BADRA2CKDM4E | |
| SCHEMBL3549463 | 0.88 | CTSB (0.43) | CTSBADRB3ADRA2BADRA2CKDM4E | |
| SCHEMBL13501953 | 0.84 | CTSB (0.56) | CTSBADRB3ADRA2BADRA2CCTSS | |
| SCHEMBL3548252 | 0.82 | CTSB (0.41) | CTSBADRB3ADRA2BADRA2C | |
| SCHEMBL2841176 | 0.81 | ADRB3 (0.39) | CTSBADRB3ADRA2BADRA2CCTSS | |
| SCHEMBL8248105 | 0.80 | CTSB (0.51) | CTSBADRB3ADRA2BADRA2CKDM4E | |
| SCHEMBL3546837 | 0.79 | ADRB3 (0.49) | CTSBADRB3ADRA2BADRA2CCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1912981-B1 | MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS | TIBOTEC PHARM LTD (IE) | 2010-01-20 | — | — | EP | disclosed |